Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
Substituted heterocyclic derivatives are provided which have the structurewherein Z1 is (CH2)q or C═O;    In addition, a method is provided for treating diabetes, Type 2 diabetes, insulin resistance, hyperglycemia, hyperinsulinemia, elevated blood levels of fatty acids or glycerol, hyperlipidemia, obesity, hypertriglyceridemia, Syndrome X, or atherosclerosis, wherein the substituted heterocyclic derivatives are administered in a therapeutically effective amount to a patient.
Bristol-Myers Squibb Company
A A C A A A A A A A C A A A
A61P A61P C07D A61P A61P A61P A61P A61P A61P A61P C07D A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Charles Z. Pratik Wei Timothy F. Xiang-Yang Hao Sean Peter T. W. Shung
Ding Devasthale Wang Herpin Ye Zhang Chen Cheng Wu